Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Announces Third Quarter 2009 Results
11/3/2009 8:35:35 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
10/27/2009 8:43:59 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Expands Management Team
10/22/2009 11:50:27 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
10/16/2009 9:08:01 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) to Present At the 2009 Maxim Group Growth Conference in New York
9/25/2009 8:35:01 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Provides Update on Corporate Developments and Third Quarter Sales Trends
9/21/2009 8:50:07 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) (JOBS) Sees Lower Q3 Acthar Sales
9/21/2009 6:46:11 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) to Present At the 2009 UBS Global Life Sciences Conference in New York
9/18/2009 12:40:24 PM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) to Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
8/3/2009 10:46:47 AM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week
7/27/2009 9:06:31 AM
More...
|
|